author-photo

Etienne Guillot

22

Papers

410

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Lysophosphatidic acid receptor agonism: discovery of potent non-lipid benzofuran ethanolamine structures.

2020 Journal of Pharmacology and Experimental Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Exploring the fate of inhaled monoclonal antibody in the lung parenchyma by microdialysis

2019 mAbs
Show All
- Source
- Cite
- Save
Citations (11)
3071Peptidomimetic targeting of CavBeta2 improves contractility in models of senescence- or genetically (MYBPC3 KI)-induced heart failure

2019 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (1)
Alirocumab decreases plasma Lp(a) levels without enhancing Lp(a) liver uptake in vivo

2018 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)
PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate

2018 Clinical Science
Show All
- Source
- Cite
- Save
Citations (24)
The complexity of lipoprotein (a) lowering by PCSK9 monoclonal antibodies

2017 Clinical Science
Show All
- Source
- Cite
- Save
Citations (25)
Alirocumab efficiently reduces Lp(a) levels by lowering apolipoprotein (a) [apo(a)] production rate in non-human primates (NHP)

2017 Atherosclerosis
Show All
- Source
- Cite
- Save
Citations (0)
Synthesis and multiparametric evaluation of thiadiazoles and oxadiazoles as diacylglycerol acyltransferase type 1 inhibitors

2016 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (4)
Discovery of SAR184841, a potent and long-lasting inhibitor of 11β-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D

2013 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (10)
Thiadiazoles as new inhibitors of diacylglycerol acyltransferase type 1.

2012 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (23)